| CTRI Number |
CTRI/2026/02/103950 [Registered on: 16/02/2026] Trial Registered Prospectively |
| Last Modified On: |
15/02/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Study on adults with Knee Osteoarthritis to compare the effect of two Ayurvedic medicated ghees, Sarvamayantaka Ghrita and Guggulutiktaka Ghrita, given through enema and oral intake, on symptoms and daily movement ability. |
|
Scientific Title of Study
|
AN OPEN LABEL RANDOMIZED COMPARATIVE CLINICAL STUDY TO EVALUATE THE COMBINED EFFICACY OF MATRA BASTI AND SHAMANA SNEHAPANA WITH SARVAMAYANTAKA GHRITA OVER GUGGULUTIKTAKA GHRITA IN JANU SANDHIGATA VATA vis-á-vis KNEE OSTEOARTHRITIS |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr RAKSHITH KUMAR L |
| Designation |
PG Scholar |
| Affiliation |
JSS Ayurveda Medical College and Hospital |
| Address |
Kayachikitsa OPD No - 1
JSS Ayurveda Medical College and Hospital
41 E Lalithadripura Road Alanahalli Mysuru
Mysuru
KARNATAKA
570028
India
Mysore KARNATAKA 570028 India |
| Phone |
8217523930 |
| Fax |
|
| Email |
rakshith170717@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr BEENA M D |
| Designation |
Professor |
| Affiliation |
JSS Ayurveda Medical College and Hospital |
| Address |
Kayachikitsa OPD No - 1
JSS Ayurveda Medical College and Hospital
41 E Lalithadripura Road Alanahalli Mysuru
Mysuru
KARNATAKA
570028
India
Mysore KARNATAKA 570028 India |
| Phone |
9538367282 |
| Fax |
|
| Email |
drpbsreddy@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr BEENA M D |
| Designation |
Professor |
| Affiliation |
JSS Ayurveda Medical College and Hospital |
| Address |
Kayachikitsa OPD No - 1
JSS Ayurveda Medical College and Hospital
41 E Lalithadripura Road Alanahalli Mysuru
Mysuru
KARNATAKA
570028
India
Mysore KARNATAKA 570028 India |
| Phone |
9538367282 |
| Fax |
|
| Email |
drpbsreddy@yahoo.com |
|
|
Source of Monetary or Material Support
|
| Materials required for the treatment Sarvamayantaka Ghrita will be prepared from the GMP
certified pharmacy and Guggulutiktaka Ghrita will be Procured from the GMP certified pharmacy. |
|
|
Primary Sponsor
|
| Name |
Dr RAKSHITH KUMAR L |
| Address |
Kayachikitsa OPD no 1
JSS Ayurveda Medical College and Hospital
41 E Lalithadripura Road Alanahalli Mysuru
Mysore
|
| Type of Sponsor |
Other [SELF] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr RAKSHITH KUMAR L |
JSS Ayurveda Medical College and Hospital |
Kayachikitsa OPD no 1 Mysore KARNATAKA |
08217523930
rakshith170717@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Clearance Committee Human |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:M179||Osteoarthritis of knee, unspecified. Ayurveda Condition: SANDHIGATAVATAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: SARVAMAYANTAKA GHRITA, Reference: Sahasrayogam, Route: Rectal, Dosage Form: Ghrita, Dose: 75(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 9 Days, anupAna/sahapAna: No, Additional Information: -(2) Medicine Name: SARVAMAYANTAKA GHRITA, Reference: Sahasrayogam, Route: Oral, Dosage Form: Ghrita, Dose: 12(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Sukhoshna Jala), Additional Information: - | | 2 | Comparator Arm | Drug | Classical | | (1) Medicine Name: GUGGULUTIKTAKA GHRITA, Reference: Ashtanga Hridaya, Route: Rectal, Dosage Form: Ghrita, Dose: 75(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 9 Days, anupAna/sahapAna: No, Additional Information: -(2) Medicine Name: GUGGULUTIKTAKA GHRITA, Reference: Ashtanga Hridaya, Route: Oral, Dosage Form: Ghrita, Dose: 12(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Sukhoshna Jala), Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
30.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1. Subjects fulfilling the diagnostic criteria.
2. Subjects of either gender, aged between 30-70 years, irrespective of socio-economic status.
3. Subjects willing to provide informed consent for the study. |
|
| ExclusionCriteria |
| Details |
1. Subjects with Infections, Neoplasms, Congenital diseases of the Knee Joint, Rheumatoid arthritis, Psoriatic arthritis and Gouty arthritis.
2. Subjects with a history of injury (less than 3 months) and any fractures of the Knee Joint.
3. Pregnant and lactating women. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
Change in WOMAC score.
|
Day 0, before treatment
Day 10, after Matra Basti
Day 40, after completion of treatment |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Range of Movements of Knee Joint- Flexion and Extension measured using Goniometer.
2. Reduction in Knee Joint swelling measured by girth at superior pole of patella.
3. Reduction in Crepitus.
4. Reduction in Tenderness. |
Day 0, before treatment
Day 10, after Matra Basti
Day 40, after completion of treatment |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
10/04/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Knee osteoarthritis, comparable to Janu Sandhigata Vata in Ayurveda, is a progressive degenerative joint disorder characterized by pain, swelling, crepitus, and restricted movement. Nearly 45 percent of individuals develop knee osteoarthritis during their lifetime, with over 365 million cases reported globally, making it a major cause of disability in older adults. Long-term dependence on NSAIDs for symptom relief leads to gastrointestinal, renal, and cardiovascular adverse effects, highlighting the need for safer long-term management options . Ayurveda considers Basti as the principal therapy for Vata disorders. Matra Basti is suitable for prolonged use and is indicated in Vata Vikara. Sarvamayantaka Ghrita, described in Sahasrayogam, is indicated in eighty types of Vata Roga and contains drugs with anti-inflammatory, analgesic, nourishing, and joint-stabilizing actions. Guggulutiktaka Ghrita, indicated in Sandhigata Vata, acts on pain, inflammation, Ama reduction, and tissue support. This open-label randomized comparative clinical study evaluates and compares the combined efficacy of Matra Basti and Shamana Snehapana with Sarvamayantaka Ghrita over Guggulutiktaka Ghrita in the management of Janu Sandhigata Vata vis-à-vis knee osteoarthritis, with the aim of identifying an effective and safer Ayurvedic intervention for long-term disease management. |